Compare Bundamedik Tbk (BMHS) vs Kalbe Farma Tbk (KLBF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Kalbe Farma Tbk — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Kalbe Farma Tbk trades at Rp705 (market cap 34.17T, 156.61M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 22.6× Bundamedik Tbk's market cap, and Kalbe Farma Tbk is more actively traded (156.61M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | KLBF | |
|---|---|---|
Market Cap | 1.51T | 34.17T |
Volume | 536.7K | 156.61M |
Lot | 5.37K | 1.57M |
Turnover | 93.41M | 111.23B |
Average Price | 174.05 | 710.21 |
Value | 93.41M | 111.23B |
Indicative Equilibrium Price | 176 | 705 |
Indicative Equilibrium Volume | 100 | 56.1K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →
